Long GnRH-agonist protocol in an IVF program: Is it appropriate for women with normal FSH levels and high FSH/LH ratios?

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 42, Issue 10, 1997, Pages 663-668

  Yang, Jehn Hsiahn ^a   Wu, Ming Yih ^a   Chao, Kuang Han ^a   Chen, Shee Uan ^a   Ho, Hong Nerng ^a,b   Yang, Yu Shih ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Fertilization in vitro; FSH; Gonadotropins

Indexed keywords

BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ARTICLE; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; ECHOGRAPHY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; IMMUNORADIOMETRIC ASSAY; INFERTILITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PATIENT SELECTION; PREGNANCY RATE; PRIORITY JOURNAL;

BUSERELIN; COHORT STUDIES; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 0030779856     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tarlatzis BC, Pados G, Bontis J, et al: Ovarian stimulation with buserelin/HMG/HCG: Prospective randomized study of short versus long protocol. Hum Reprod 1993;8:807-812
2. Tan SL, Bradfield J, Kingsland C, et al: The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810-814
3. Toth TL, Awwas JT, Veeck LL, et al: Suppression and flare regimens of gonadotropin-releasing hormone agonist: Use in women with different basal gonadotropin values in an in vitro fertilization program. J Reprod Med 1996;41:321-326
4. Zorn JR, Barata M, Brami C, et al: Ovarian stimulation for in-vitro fertilization combining administration of gonadotrophin and blockade of pituitary with D-Trp 6-LHRH microcapsules: Pilot studies with two protocols. Hum Reprod 1988;3:235-239
5. Frydman R, Forman R, Belaisch-Allart J, et al: Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program. Fertil Steril 1988;50:471-475
6. Remorgida V, Anserini P, Crose S, et al: The duration of pituitary suppression by means of intranasal gonadotropin-releasing hormone administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program. J In Vitro Fertil Embryo Transf 1989;6:76-80
7. Tasdemir M, Tasdemir I, Kodama H, et al: Short protocol of gonadotropin releasing hormone agonist administration gave better results in long protocol poor responders. Hum Reprod (suppl 2) 1993;8:94-95
8. Olivennes F, Righini C, Fanchin R, et al: A protocol using a low dose of gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle stimulating hormone concentrations on day 3. Hum Reprod 1996;11: 1169-1172
9. Muasher SJ, Ellis LM, Oehninger S, et al: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298-307
10. Pantos K, Meimeth-Damianaki T, Vaxevanoglou T, et al: Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program. Fertil Steril 1994;61:709-713
11. Ho HN, Yang YS, Hsieh RP, et al: Sharing of human leukocyte antigens (HLA) in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer. Am J Obstet Gynecol 1994;170:63-71
12. Ho HN, Chen HF, Chen SU, et al: Gonadotropin-releasing hormone (GnRH) agonist induces suppression of CD25+CD3+ lymphocyte subpopulations in peripheral blood. Am J Reprod Immunol 1995;33:243-252
13. Sauer MV, Paulson RJ, Lobo RA: A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med 1990;23:1157-1160
14. Cahill DJ, Prosser CJ, Wardle PG, et al: Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1994;101:999-1002
15. Pearlstone AC, Pang SC, Fournet N, et al: Ovulation induction in women age 40 and older: The importance of basal follicle-stimulating hormone level and chronological age. Fertil Steril 1992;58:674-679
16. Toner JP, Philput CB, Jones GS, et al: Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-791
17. Scott RT, Oehninger S, Toner JP, et al: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651-654
18. Licciardi FL, Liu HC, Rosenwaks Z: Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995;64:991-994
19. Jones HW, Jones GS, Andrews MC, et al: The program for in vitro fertilization at Norfolk. Fertil Steril 1982;38:14-21
20. Adashi EY, Leung PCK: The ovary. New York, Raven Press, 1993, p 553
21. de Ziegler D, Lu JKH, Cedars MI, et al: Suppression of the ovary using a gonadotropin releasing-hormone agonist prior to stimulation for oocyte retrieval. Fertil Steril 1987;48:807-810
22. Fleming R, Coutts JRT: Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986;45:226-230
23. Howles CM, Macnamee MC, Edwards RG: Short-term use of an LHRH agonist to treat poor responders entering an in-vitro fertilization programme. Hum Reprod 1987;2:655-656
24. Mukherjee T, Sandler B, Copperman AB, et al: An elevated day 3 follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 1996;65:588-593